申请人:Foote Michael Kevin
公开号:US20050065157A1
公开(公告)日:2005-03-24
The use of a compound of formula (I) in the manufacture of a medicament for the treatment, in a warm-blooded animal, of disorders mediated by the neuropeptide Y5 receptor:
wherein:
R
1
, R
2
, R
3
and X
1
-X
6
are as defined within or a pharmaceutically acceptable salt, prodrug or solvate thereof, is described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are also described.
使用化合物(I)的制剂制造药物,用于治疗温血动物中由神经肽Y5受体介导的疾病:其中:R1,R2,R3和X1-X6如定义内所述或其药学上可接受的盐,前药或溶剂化物。还描述了化合物(I)的制备的药物组成,方法和过程。